Von Willebrand disease. Coordination between levels of healthcare

Authors

  • Jorge Esquivel Negrín Hospital Universitario Nuestra Señora de Candelaria. Servicio de Farmacia.
  • María Isabel Peris Fernaud Hospital Universitario Nuestra Señora de Candelaria. Servicio de Hematología y Hemoterapia.
  • María Ángeles Ocaña Gómez Hospital Universitario Nuestra Señora de Candelaria. Servicio de Farmacia.
  • Mario Ríos De Paz Hospital Universitario Nuestra Señora de Candelaria. Servicio de Hematología y Hemoterapia.
  • María Dolores De Dios García Hospital Universitario Nuestra Señora de Candelaria. Servicio de Hematología y Hemoterapia.

DOI:

https://doi.org/10.60103/phc.v27.e879

Keywords:

von Willebrand Diseases; Blood Coagulation Disorders; Intersectoral Collaboration

Abstract

Introduction: Von Willebrand disease (VWD), the most common congenital bleeding disorder, requires coordinated care between primary care and coagulation referral unit to ensure proper diagnosis and safe pharmacotherapeutic management in these patients. Objective: to study the concordance between primary care and specialised care records, and to correct the discrepancies found.

Method: A two-phase study was performed. Phase 1: review of diagnostic and treatment records for patients with VWD registered on September 1, 2023 in a coagulation unit. Diagnoeis, prescription of bleeding-risk drugs, and history of bleeding in Primary Care setting were analysed. Phase 2 (October 2023–October 2024): primary care was contacted to correct inaccurate information and adjust treatments. 

Results: A total of 106 patients (59% female, mean age 37.6 years) were included. A diagnosis of VWD was recorded in PC in 64.2%, vague diagnoses in 15.1% and 20.7% were not recorded. Eight patients (7.55%) were prescribed non-selective NSAIDs (three with no recorded diagnosis in Primary Care). After intervention by telephone or e-mail, discrepancies were reduced by 32.7% (from 35.8% to 3.1%), but the lack of a two-way telematic and protocolised communication system between care levels prevented reaching 0%.

Conclusions: Improved communication between levels of care reduced discrepancies, but systems need to be put in place to overcome organisational and logistical barriers to communication between professionals in the interest of patient safety.

Downloads

Download data is not yet available.

References

Batlle J, Perez-Rodriguez A, Pinto JC, Fraga EL, Rodriguez-Trillo Tch A, Fernanda Lopez-Fernandez M. Diagnosis and management of von Willebrand disease in Spain. Semin Thromb Hemost. 2011;37(5):503–10. doi: 10.1055/s-0031-1281036.

Fogarty H, Doherty D, O’Donnell JS. New developments in von Willebrand disease. Br J Haematol. 2020;191(3):329–39. DOI: 10.1111/bjh.16681.

Weyand AC, Flood VH. Von Willebrand Disease: Current Status of Diagnosis and Management. Hematol Oncol Clin North Am. 2021; 35(6):1085–101. doi: 10.1016/j.hoc.2021.07.004.

Colonne CK, Reardon B, Curnow J, Favaloro EJ. Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations. J Blood Med. 2021;12:755–68. doi: 10.2147/JBM.S266791.

Govorov I, Ekelund L, Chaireti R, Elfvinge P, Holmström M, Bremme K, et al. Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand’s disease. Exp Ther Med. 2016 May;11(5):1923–9. doi: 10.3892/etm.2016.3144.

VanderMeulen H, Arya S, Nersesian S, Philbert N, Sholzberg M. What have we learned about the patient’s experience of von Willebrand disease? A focus on women. Hematol Am Soc Hematol Educ Progr. 2022;2022(1):631–6. doi: 10.1182/hematología.2022000391.

Merz LE, AbdelHameid D, Kanaan DM, Farah S, Manzo P, Connell NT. Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease. Blood Adv. 2024;8(9):2244–7. doi: 10.1182/bloodadvances.2023012348.

Driver B, Marks DC, van der Wal DE. Not all (N)SAID and done: Effects of nonsteroidal anti-inflammatory drugs and paracetamol intake on platelets. Res Pract Thromb Haemost. 2020 Jan;4(1):36–45. DOI: 10.1002/rth2.12283.

Naharro Máñez AM, Tárraga López PJ. Innovando en gestión asistencial: análisis del modelo de integración primaria, especializada y sociosanitaria. Med Gen y Fam (edición Digit [Internet]. 2016;5(4):149–54. Available from: https://www.elsevier.es/es-revista-medicina-general-familia-edicion-digital--231-articulo-innovando-gestion-asistencial-analisis-del-S1889543316300081

Allepuz A, Gallardo C, Perona M. Coordinación entre niveles asistenciales: ¿qué priorizan los profesionales? Atención Primaria [Internet]. 2012;44(9):568–9. Available from: https://www.elsevier.es/es-revista-atencion-primaria-27-articulo-coordinacion-entre-niveles-asistenciales-que-S0212656712002065

Herrero Domínguez-Berrueta MC, Muñoz-García M, Delgado-Silveira E, Martín-Aragón S, Gangoso Fermoso A. Primary care pharmacist-led medication review in older adult patients in coordination with general practitioners: an observational retrospective cohorts study. Explor Res Clin Soc Pharm. 2023;13:100390. doi: 10.1016/j.rcsop.2023.100390.

Published

2025-04-04

How to Cite

Esquivel Negrín, J., Peris Fernaud, M. I., Ocaña Gómez, M. Ángeles, Ríos De Paz, M., & De Dios García, M. D. (2025). Von Willebrand disease. Coordination between levels of healthcare. Pharmaceutical Care España, 27. https://doi.org/10.60103/phc.v27.e879

Issue

Section

Originales